Bioceres Crop Solutions Corp. Ordinary Shares (BIOX) is a publicly traded Basic Materials sector company. As of May 21, 2026, BIOX trades at $0.44 with a market cap of $27.97M and a P/E ratio of 0.00. BIOX moved +3.09% today. Year to date, BIOX is -70.13%; over the trailing twelve months it is -90.75%. Its 52-week range spans $0.35 to $8.23. Rallies surfaces BIOX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bioceres Reports 40% H1 Gross Margin, $179M Impairment on Pro Farm: Bioceres generated a consolidated gross margin of 40% for the six months ended December 2025 while facing Argentine farmer credit pressure and commodity weakness. The company recorded a $179 million impairment loss after a $15 million foreclosure auction on Pro Farm assets and flagged substantial going-concern doubt.
| Metric | Value |
|---|---|
| Price | $0.44 |
| Market Cap | $27.97M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.23 |
| 52-Week Low | $0.35 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BIOX analyst coverage data. Average price target: $0.00.